Improve Safety in Polymedication by Managing Drug-Drug-Gene Interactions

Project Information

SafePolyMed

Grant agreement ID: 101057639

DOI

10.3030/101057639

EC signature date 23 May 2022

Start date 1 June 2022

End date 30 November 2025

Funded under

• Health

Total cost

€ 5 650 444,56

EU contribution

€ 5 650 442,81

Coordinated by

UNIVERSITAT DES SAARLANDES
Germany

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Websites, patent fillings, videos etc. (2)

Public Project Website
Audio-visual material

Documents, reports (5)

Selection of clinically relevant compounds
English-Estonian dictionary
Content for the training curriculum for empowerment of patients in pharmacology and drug safety
Design and implementation of the SafePolyMed platform for the analysis of the retrospective data
Patient engagement Hub: setup of a priority setting network of different patient organisations

Publications

Peer reviewed articles (1)

Genetic predictors of lifelong medication-use patterns in cardiometabolic diseases

Author(s): Tuomo Kiiskinen, Pyry Helkkula, Kristi Krebs, Juha Karjalainen, Elmo Saarentaus, Nina Mars, Arto Lehisto, Wei Zhou, Mattia Cordioli, Sakari Jukarainen, Joel T. Rämö, Juha Mehtonen, Kumar Veerapen, Markus Räsänen, Sanni Ruotsalainen, Mutaamba Maasha, F
Published in: Nature Medicine, Issue 29, 2023, ISSN 1078-8956
Publisher: Nature Medicine (Nat Med)
DOI: 10.1038/s41591-022-02122-5